Search Results - Lisa Blixt
- Showing 1 - 4 results of 4
-
1
Uptake of the first to fifth doses of coronavirus disease 2019 vaccine in individuals with chronic lymphocytic leukaemia: A nationwide cohort study in Sweden by Pontus Hedberg, Lisa Blixt, Fredrik Granath, Peter Bergman, Christina Carlander, Soo Aleman, Lotta Hansson, the CLHIP study group
Published in eJHaem (2025-02-01)Get full text
Article -
2
T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical tr... by Lisa Blixt, David Wullimann, Soo Aleman, Jeanette Lundin, Puran Chen, Yu Gao, Angelica Cuapio, Mira Akber, Joshua Lange, Olga Rivera-Ballesteros, Marcus Buggert, Hans-Gustaf Ljunggren, Lotta Hansson, Anders Österborg
Published in Haematologica (2022-01-01)Get full text
Article -
3
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era by Pontus Hedberg, Lisa Blixt, Sandra Eketorp Sylvan, Isabela Killander Möller, Hannes Lindahl, Fredrik Kahn, Åsa Nilsdotter-Augustinsson, Mats Fredrikson, Sofia Nyström, Peter Bergman, Christina Carlander, Soo Aleman, Pontus Nauclér, Anders Österborg, Lotta Hansson
Published in Blood Advances (2025-07-01)Get full text
Article -
4
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia by Hanna M. Ingelman-Sundberg, Lisa Blixt, David Wullimann, Jinghua Wu, Yu Gao, Katie Healy, Sandra Muschiol, Gordana Bogdanovic, Mikael Åberg, Christian Kjellander, Alba Grifoni, Alessandro Sette, Soo Aleman, Puran Chen, Ola Blennow, Lotta Hansson, Hans-Gustaf Ljunggren, Margaret Sällberg Chen, Marcus Buggert, Anders Österborg
Published in Haematologica (2023-08-01)Get full text
Article
